Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)

The National Institutes of Health (NIH) has introduced the Cancer Research Education Grants Program, specifically for research experiences. The program, referred to as R25, explicitly prohibits clinical trials. R25, as an educational program with a key emphasis on Research Experiences, is vital in the furthering of the NIH's mission.

The major objective of this program developed by the National Cancer Institute (NCI) is fostering educational approaches that can augment and potentially enhance the training of the workforce. This team will be responsible for meeting the country's needs in the realms of biomedical, behavioral, and clinical research.

To effectively enact this aim, the Funding opportunity announcement (FOA) will provide support for educational activities with groundbreaking and state-of-the-art programs. It encourages applications that suggest innovative programs, which specifically address various aspects of cancer. These aspects include identifying the cause, diagnosing, preventing and treating cancer, rehabilitating from cancer, and taking care of cancer patients ongoingly.

Moreover, applications that propose methods for the ongoing care of cancer patients and their families are highly encouraged. This comprehensive approach is designed to tackle all stages of the cancer journey, from detection to recovery and beyond, thereby underpinning every aspect of cancer care.